ReviewAesthetic plastic surgery2025
Technological Advances in Anti-hair Loss and Hair Regrowth Cosmeceuticals: Mechanistic Breakthroughs and Industrial Prospects Driven by Multidisciplinary Collaborative Innovation.
Review in Aesthetic plastic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Bio-inspired suction cup microneedle loaded fusion membrane targeting nano-drug delivery system treat androgenetic alopecia.Journal of nanobiotechnology · 2026Article
- Overview of Short Peptides for Hair Loss.Biomedicines · 2026Review
- Article
- Adjunctive regenerative therapies in hair transplantation: a comprehensive review of platelet-rich plasma, exosomes, and emerging methods.Frontiers in medicine · 2026Review
- Complications in follicular unit excision hair transplantation: current evidence and practical approaches.Frontiers in medicine · 2026Review
- Androgenetic alopecia.Nature reviews. Disease primers · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
In light of the escalating global prevalence of hair loss, there is an imperative to explore strategies for the prevention and promotion of hair growth. This article reviews the current situation, challenges, innovations, and prospects of cosmetics that promote anti-hair loss and hair growth. Firstly, the physiological and pathological mechanisms of hair loss, including androgenetic alopecia, telogen effluvium, and alopecia areata, as well as the influence of genetic, environmental, and lifestyle factors, are explored. Subsequently, a comprehensive analysis of the predominant product categories and ingredients currently available on the market was conducted, encompassing minoxidil, finasteride, plant extracts, growth factors, and peptides. Building on this, this article further explores the challenges of anti-hair loss and hair growth promotion cosmetics, including effectiveness and safety, consumer acceptance, and the complexity of regulations and standards. This was followed by an introduction to innovations in the field, such as gene therapy, stem cell technology, and microneedling, as well as advanced delivery systems and personalized care options. Finally, this paper looks forward to future technologies' development trends and market prospects. It emphasizes the importance of multidisciplinary cooperation, including the combination of medicine and cosmetology and the integration of biotechnology and materials science. By synthesizing extant research and delineating prospective research directions, this paper establishes an indispensable reference point for the research and development of cosmetics designed to promote hair growth and prevent hair loss.Level of Evidence V This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.